Article: Adacel, Focalin XR.(New & Approved)(dexmethylphenidate hydrochloride)(tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine)

Adacel (tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed, Aventis Pasteur)

The Food and Drug Administration approved Adacel, a new vaccine for single booster immunization against pertussis (whooping cough) in combination with tetanus and diphtheria, for patients 11-64 years old.

* Recommended Dosage: A single intramuscular injection of one dose (0.5 mL).

* Special Considerations: Pain at injection site was the most commonly reported adverse event in a study that included 1,184 adolescents given Adacel and 792 given a comparison vaccine, tetanus and diphtheria toxoids adsorbed for adult use (Td) vaccine. ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!